Bencardino, S.; Bernardi, F.; Allocca, M.; Zilli, A.; Furfaro, F.; Peyrin-Biroulet, L.; Danese, S.; D’Amico, F.
Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What’s New? Cancers 2025, 17, 1710.
https://doi.org/10.3390/cancers17101710
AMA Style
Bencardino S, Bernardi F, Allocca M, Zilli A, Furfaro F, Peyrin-Biroulet L, Danese S, D’Amico F.
Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What’s New? Cancers. 2025; 17(10):1710.
https://doi.org/10.3390/cancers17101710
Chicago/Turabian Style
Bencardino, Sarah, Francesca Bernardi, Mariangela Allocca, Alessandra Zilli, Federica Furfaro, Laurent Peyrin-Biroulet, Silvio Danese, and Ferdinando D’Amico.
2025. "Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What’s New?" Cancers 17, no. 10: 1710.
https://doi.org/10.3390/cancers17101710
APA Style
Bencardino, S., Bernardi, F., Allocca, M., Zilli, A., Furfaro, F., Peyrin-Biroulet, L., Danese, S., & D’Amico, F.
(2025). Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What’s New? Cancers, 17(10), 1710.
https://doi.org/10.3390/cancers17101710
